Adirondack Trust Company’s ADMA Biologics ADMA Stock Holding History

Adirondack Trust Company’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.32K	Sell	516 -20	-4%	-$182	﹤0.01%	490
2026 Q1	$4.83K	Hold	536	–	–	﹤0.01%	454
2025 Q4	$9.77K	Hold	536	–	–	﹤0.01%	395
2025 Q3	$7.86K	Sell	536 -49	-8%	-$840	﹤0.01%	412
2025 Q2	$10.6K	Hold	585	–	–	﹤0.01%	357
2025 Q1	$11.6K	Hold	585	–	–	﹤0.01%	336
2024 Q4	$10K	Hold	585	–	–	﹤0.01%	360
2024 Q3	$11.7K	Hold	585	–	–	﹤0.01%	349
2024 Q2	$6.54K	Hold	585	–	–	﹤0.01%	386
2024 Q1	$3.86K	Hold	585	–	–	﹤0.01%	429
2023 Q4	$3.13K	Buy	+585	New	+$2.16K	﹤0.01%	439

Other funds holding ADMA

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Adirondack Trust Company's ADMA Position: Q2 2026 in Review

Adirondack Trust Company reduced its ADMA Biologics (ADMA) stake by 3.7% in Q2 2026, selling an estimated $182 and leaving 516 shares worth $4.32K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Adirondack Trust Company first reported a position in ADMA in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.7K in Q3 2024. 54 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Adirondack Trust Company held 516 shares of ADMA Biologics worth $4.32K as of Q2 2026.
Adirondack Trust Company sold 20 ADMA Biologics shares in Q2 2026, an estimated $182.
ADMA Biologics made up ﹤0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #490 holding.
Adirondack Trust Company first reported a position in ADMA Biologics in Q4 2023 and has held it in 11 quarters since.
Adirondack Trust Company's ADMA Biologics position peaked at $11.7K in Q3 2024.
54 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.